These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 33016076)

  • 1. The potential role of the eGFR in differentiating between true and pseudohyperkalaemia.
    Morris TG; Lamba S; Fitzgerald T; Roulston G; Johnstone H; Mirzazadeh M
    Ann Clin Biochem; 2020 Nov; 57(6):444-455. PubMed ID: 33016076
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A case of severe pseudohyperkalaemia due to muscle contraction.
    Van Elslande J; Dominicus T; Toelen J; Frans G; Vermeersch P
    Biochem Med (Zagreb); 2020 Jun; 30(2):021004. PubMed ID: 32550820
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Investigation of outpatients referred to a chemical pathologist with potential pseudohyperkalaemia.
    Kapoor AK; Ravi A; Twomey PJ
    J Clin Pathol; 2009 Oct; 62(10):920-3. PubMed ID: 19783721
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Leaky cell syndrome: a rare cause of pseudohyperkalaemia.
    Lukens MV; de Mare A; Kerbert-Dreteler MJ; van den Bergh FA
    Ann Clin Biochem; 2012 Jan; 49(Pt 1):97-100. PubMed ID: 22042978
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence and factors associated with false hyperkalaemia in Asians in primary care: a cross-sectional study (the Unlysed Hyperkalaemia- the Unseen Burden (UHUB) study).
    Boo AYY; Koh YLE; Hu PL; Tan NC
    BMJ Open; 2020 Sep; 10(9):e033755. PubMed ID: 32963061
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Must we always treat hyperkalaemia?].
    Basile C; Manobianca G; Bruno A; Tamma F
    G Ital Nefrol; 2013; 30(1):. PubMed ID: 23832444
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A case of undiagnosed pseudohyperkalaemia following a splenectomy.
    Grech M
    Age Ageing; 2018 Sep; 47(5):758-759. PubMed ID: 29757348
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pseudohyperkalaemia associated with leukaemic cell lysis during pneumatic tube transport of blood samples.
    Dickinson H; Webb NJ; Chaloner C; Wynn RF; Bonney DK
    Pediatr Nephrol; 2012 Jun; 27(6):1029-31. PubMed ID: 22366875
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pseudohyperkalaemia in essential thrombocytosis: an important clinical reminder.
    Mizzi JM; Rizzo C; Fava S
    Endocrinol Diabetes Metab Case Rep; 2021 Apr; 2021():. PubMed ID: 33960323
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Implications of differences between point-of-care blood gas analyser and laboratory analyser potassium results on hyperkalaemia diagnosis & treatment.
    Pradhan J; Harding AM; Taylor SE; Lam Q
    Intern Med J; 2023 Nov; 53(11):2035-2041. PubMed ID: 36645311
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hyperkalemia After Initiating Renin-Angiotensin System Blockade: The Stockholm Creatinine Measurements (SCREAM) Project.
    Bandak G; Sang Y; Gasparini A; Chang AR; Ballew SH; Evans M; Arnlov J; Lund LH; Inker LA; Coresh J; Carrero JJ; Grams ME
    J Am Heart Assoc; 2017 Jul; 6(7):. PubMed ID: 28724651
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluating the risk of hyperkalaemia and acute kidney injury with cotrimoxazole: a retrospective observational study.
    Rajput J; Moore LSP; Mughal N; Hughes S
    Clin Microbiol Infect; 2020 Dec; 26(12):1651-1657. PubMed ID: 32220637
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Risk for hyperkalemia during long-term treatment with angiotensin-converting enzyme inhibitors in insulin-dependent type 2 diabetics in relation to the glomerular filtration rate].
    Raml A; Schmekal B; Grafinger P; Biesenbach G
    Dtsch Med Wochenschr; 2001 Nov; 126(47):1327-30. PubMed ID: 11719857
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The impact of centrifugation in primary care on pseudohyperkalaemia: a retrospective evaluation.
    Turner HE; Peake RW; Allison JJ
    Ann Clin Biochem; 2013 Jul; 50(Pt 4):371-3. PubMed ID: 23761382
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pseudohyperkalaemia is a common finding in myeloproliferative disorders that may lead to inappropriate management of patients.
    Ong YL; Deore R; El-Agnaf M
    Int J Lab Hematol; 2010 Feb; 32(1 Pt 1):e151-7. PubMed ID: 19016918
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pseudohyperkalaemia in thrombocythaemia.
    Wulkan RW; Michiels JJ
    J Clin Chem Clin Biochem; 1990 Jul; 28(7):489-91. PubMed ID: 2230668
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Safety and efficacy of eplerenone in patients at high risk for hyperkalemia and/or worsening renal function: analyses of the EMPHASIS-HF study subgroups (Eplerenone in Mild Patients Hospitalization And SurvIval Study in Heart Failure).
    Eschalier R; McMurray JJ; Swedberg K; van Veldhuisen DJ; Krum H; Pocock SJ; Shi H; Vincent J; Rossignol P; Zannad F; Pitt B;
    J Am Coll Cardiol; 2013 Oct; 62(17):1585-93. PubMed ID: 23810881
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of the concurrent use of potassium-influencing drugs as risk factors for the development of hyperkalemia.
    Kuijvenhoven MA; Haak EA; Gombert-Handoko KB; Crul M
    Int J Clin Pharm; 2013 Dec; 35(6):1099-104. PubMed ID: 23974985
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Prevalence and related factors of hyperkalemia in patients with diabetic kidney disease].
    Li SY; Li GP; Wang L; Duan JY; Chen WQ; Pan SK; Liu ZS; Liu DW
    Zhonghua Yi Xue Za Zhi; 2021 Nov; 101(42):3478-3483. PubMed ID: 34775705
    [No Abstract]   [Full Text] [Related]  

  • 20. ACE-inhibitor or AT2-antagonist therapy of renal transplant recipients is associated with an increase in serum potassium concentrations.
    Mitterbauer C; Heinze G; Kainz A; Kramar R; Hörl WH; Oberbauer R
    Nephrol Dial Transplant; 2008 May; 23(5):1742-6. PubMed ID: 18234845
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.